HRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access ...
According to Future Market Insights, the global bioactive peptide market is projected to grow from 3.5 billion USD in 2026 to 6.0 billion USD by 2036, with a compound annual growth rate (CAGR) of 5.5% ...
SAN DIEGO, CA, UNITED STATES, September 23, 2026 /EINPresswire.com/ -- Peptide drugs exhibit unparalleled advantages in ...
AVS Bio, a portfolio company of Arlington Capital Partners, has acquired Biorbyt, a Cambridge, UK-based supplier of research antibodies, proteins, and other biomaterials. The acquisition expands AVS ...
Trade Brains on MSN
Can Divi's Laboratories Custom Synthesis Continue Delivering Growth
India, Sept. 23 -- Every quarter, this API maker's earnings call turns into the same tug of war. Analysts ask how much of the ...
If you’d love to hit up Sephora for some retail therapy but worry your bank account can’t handle it, here’s a great idea: ...
Dark spots are one of most common signs of skin aging. In general, an anti-aging serum that contains exfoliating ingredients, ...
Precision medicine, advanced diagnostics and ADCs are driving outsourced custom conjugation, novel labels and automation, with opportunities in emerging marketsDublin, Sept. 21, 2026 (GLOBE NEWSWIRE) ...
Missed Shop TODAY On Campus? Shop along at home: portable Bissell sweatshirts, personalized insoles, custom Zenni glasses, ...
More than one billion people worldwide live with migraines, and, for many, managing them remains a challenge. That’s because ...
The acquisition will help expand AVS Bio’s biomaterials offering and ecommerce capabilitiesNORWICH, Conn.--(BUSINESS WIRE)--AVS Bio (the “Company”), a leading global provider of critical inputs and ...
Fall has officially reached the warehouse.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results